Friedenthal Financial’s iShares Biotechnology ETF IBB Stock Holding History

Friedenthal Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,510	Closed	-$204K	–	52
2020 Q3	$204K	Buy	+1,510	New	+$205K	0.16%	50
2015 Q3	–	Sell	-58,734	Closed	-$7.22M	–	41
2015 Q2	$7.22M	Sell	58,734 -1,641	-3%	-$196K	6.27%	4
2015 Q1	$6.91M	Sell	60,375 -1,248	-2%	-$138K	5.85%	9
2014 Q4	$6.23M	Buy	+61,623	New	+$5.99M	5.29%	11
2014 Q1	–	Sell	-93,879	Closed	-$7.11M	–	37
2013 Q4	$7.11M	Buy	+93,879	New	+$6.66M	6.58%	9

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Friedenthal Financial's IBB Position: Q4 2020 in Review

Friedenthal Financial sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 1,510 shares — an estimated $204K sold.

Friedenthal Financial first reported a position in IBB in Q4 2013 and held it in 5 quarters. The position peaked at $7.22M in Q2 2015. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Friedenthal Financial reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Friedenthal Financial sold 1,510 iShares Biotechnology ETF shares in Q4 2020, an estimated $204K.
Friedenthal Financial first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 5 quarters.
Friedenthal Financial's iShares Biotechnology ETF position peaked at $7.22M in Q2 2015.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Friedenthal Financial's 13F filing for Q4 2020, filed 4 Feb 2021.